Literature DB >> 20541667

Pathogenesis of pituitary tumors.

Run Yu1, Shlomo Melmed.   

Abstract

Pituitary tumors are common and mostly benign neoplasia which cause excess or deficiency of pituitary hormones and compressive damage to adjacent organs. Oncogene activation [e.g. PTTG (pituitary tumor-transforming gene) and HMGA2], tumor suppressor gene inactivation (e.g. MEN1 and PRKAR1A), epigenetic changes (e.g. methylation) and humoral factors (e.g. ectopic production of stimulating hormones) are all possible pituitary tumor initiators; the micro-environment of pituitary tumors including steroid milieu, angiogenesis and abnormal cell adhesion further promote tumor growth. Senescence, a cellular defence mechanism against malignant transformation, may explain the benign nature of at least some pituitary tumors. We suggest that future research on pituitary tumor pathogenesis should incorporate systems approaches, and address regulatory mechanisms for pituitary cell proliferation, development of new animal models of pituitary tumor and isolation of functional human pituitary tumor cell lines. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20541667     DOI: 10.1016/S0079-6123(10)82009-6

Source DB:  PubMed          Journal:  Prog Brain Res        ISSN: 0079-6123            Impact factor:   2.453


  10 in total

1.  Prognostic implications of securin expression and sub-cellular localization in human breast cancer.

Authors:  N Gurvits; H Repo; E Löyttyniemi; M Nykänen; J Anttinen; T Kuopio; K Talvinen; P Kronqvist
Journal:  Cell Oncol (Dordr)       Date:  2016-03-16       Impact factor: 6.730

2.  mTOR promotes pituitary tumor development through activation of PTTG1.

Authors:  R Chen; J Duan; L Li; Q Ma; Q Sun; J Ma; C Li; X Zhou; H Chen; Y Jing; S Zhao; X Wu; H Zhang
Journal:  Oncogene       Date:  2016-08-15       Impact factor: 9.867

Review 3.  Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene.

Authors:  Albert Beckers; Lauri A Aaltonen; Adrian F Daly; Auli Karhu
Journal:  Endocr Rev       Date:  2013-01-31       Impact factor: 19.871

4.  Expression stability of reference genes for quantitative RT-PCR of healthy and diseased pituitary tissue samples varies between humans, mice, and dogs.

Authors:  Sarah J van Rijn; Frank M Riemers; Douwe van den Heuvel; Jeannette Wolfswinkel; Leo Hofland; Björn P Meij; Louis C Penning
Journal:  Mol Neurobiol       Date:  2013-10-18       Impact factor: 5.590

5.  Cyclin A in nonfunctioning pituitary adenomas.

Authors:  Elisa B Lamback; Alexandro Guterres; Monique Alvares Barbosa; Carlos Henrique de Azeredo Lima; Debora Aparecida Silva; Aline Helen da Silva Camacho; Leila Chimelli; Leandro Kasuki; Mônica R Gadelha
Journal:  Endocrine       Date:  2020-07-03       Impact factor: 3.633

6.  Long non-coding RNA TUG1/microRNA-187-3p/TESC axis modulates progression of pituitary adenoma via regulating the NF-κB signaling pathway.

Authors:  Rui Zhang; Fan Yang; Haitao Fan; Haocong Wang; Qinghao Wang; Jianxin Yang; Tao Song
Journal:  Cell Death Dis       Date:  2021-05-21       Impact factor: 8.469

7.  Targeting the ERK pathway for the treatment of Cushing's disease.

Authors:  Dongyun Zhang; Marvin Bergsneider; Marilene B Wang; Anthony P Heaney
Journal:  Oncotarget       Date:  2016-10-25

8.  EIF1A depletion restrains human pituitary adenoma progression.

Authors:  Rongxin Geng; Xiaonan Zhu; Xiang Tao; Junhui Liu; Haitao Xu
Journal:  Transl Oncol       Date:  2021-12-01       Impact factor: 4.243

9.  Functional Characteristics of Multipotent Mesenchymal Stromal Cells from Pituitary Adenomas.

Authors:  Kaspars Megnis; Ilona Mandrika; Ramona Petrovska; Janis Stukens; Vita Rovite; Inga Balcere; Laima Sabine Jansone; Raitis Peculis; Valdis Pirags; Janis Klovins
Journal:  Stem Cells Int       Date:  2016-06-02       Impact factor: 5.443

10.  Detection of circulating tumor cells in patients with pituitary tumors.

Authors:  Gao Hua; He Yanjiao; Liu Qian; Wang Jichao; Zhang Yazhuo
Journal:  BMC Cancer       Date:  2018-03-27       Impact factor: 4.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.